Day One | Targeted Therapies for Patients of All Ages | Home
We exist to help people of all ages, from day one and every day after. Ready to make an impact. Learn more about our FDA-approved medicine for pediatric patients with relapsed or refractory pediatric low-grade glioma (pLGG).
Day One Biopharmaceuticals, Inc. (DAWN) Stock Price, News, …
Find the latest Day One Biopharmaceuticals, Inc. (DAWN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Day One Expands Pipeline with Potential First-in-Class Clinical …
Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in April 2024. Targets PTK7, highly expressed in broad range...
Day One Expands Pipeline with Potential First-in-Class Clinical …
Jun 18, 2024 · Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™) and pimasertib.
News for the Community - Day One Bio
On January 8, 2023, Day One announced top-line results from our ongoing pivotal Phase 2 FIREFLY-1 trial of tovorafenib (DAY101) in patients with recurrent or progressive pediatric low-grade glioma, or pLGG. For more details, the complete press release is available here. 2022
4 ‘Day One’ Promises From President-Elect Donald Trump - U.S. News …
Dec 9, 2024 · Former President Donald Trump made a variety of promises throughout his campaign about what would happen on Day One of his presidency, including vowing to be “a dictator,” ending Russia ’s war...
Day One Announces New FIREFLY-1 Data for Tovorafenib …
FIREFLY-1, an open-label, pivotal Phase 2 trial, treated 77 patients and evaluated tovorafenib as a once-weekly monotherapy in patients aged 6 months to 25 years with relapsed or progressive pLGG...
Day One Reports First Quarter 2023 Financial Results and …
BRISBANE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced its first quarter 2023 financial results and highlighted recent corporate ...
Trump team readies a flurry of executive actions for Day 1 - NBC News
Nov 21, 2024 · Trump is preparing on Day One to overturn specific policies put in place by Biden, with plans to end travel reimbursement for military members seeking abortion care and to restrict transgender...
What Donald Trump's Day 1 Looks Like, per His Aides
Nov 6, 2024 · Donald Trump's campaign team and advisers have said what the Republican will do on the first day of his return to the White House following his 2024 election victory.